Cyclo(Gly-Gln) inhibits the cardiorespiratory depression produced by β-endorphin and morphine

Brain Research

Volumn 747, Issue 1, 1997, Pages 52-59

  Unal, Can B ^a   Owen, Medge D ^a   Millington, William R ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

cardiovascular regulation; dipeptide; glycyl L glutamine; opioid; post translational processing; pro opiomelanocortin

Indexed keywords

BETA ENDORPHIN; GLYCYLGLUTAMINE; MORPHINE;

ANIMAL EXPERIMENT; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; HYPOTENSION; INTRAARTERIAL DRUG ADMINISTRATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATION DEPRESSION;

ANIMALS; BETA-ENDORPHIN; BLOOD PRESSURE; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; HEMODYNAMIC PROCESSES; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENTRICULAR; MALE; MORPHINE; NARCOTIC ANTAGONISTS; NARCOTICS; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY INSUFFICIENCY; RESPIRATORY MECHANICS;

EID: 0031049657     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01261-9     Document Type: Article

References (42)

1. Akil, H., Young, E. and Watson, S.J., Opiate binding properties of naturally occurring N- and C-terminus modified beta-endorphins, Peptides, 2 (1981) 289-292.
2. Bals-Kubik, R., Herz, A. and Shippenberg, T.S., β-Endorphin-(1-27) is a naturally occurring antagonist of the reinforcing effects of opioids, N.-S. Arch. Pharmacol., 338 (1988) 392-396.
3. Banks, W.A., Kastin, A.J., Akerstrom, V. and Jaspan, J.B., Radioactively iodinated cyclo(His-Pro) crosses the blood-brain barrier and reverses ethanol-induced narcosis, Am. J. Physiol., 264 (1993) E723-E729.
4. Bauer, K., Gräf, K.J., Faivre-Bauman, A., Beier, S., Tixier-Vidal, A. and Kleinkauf, H., Inhibition of prolactin secretion by histidyl-proline-diketopiperazine, Nature, 274 (1978) 174-175.
5. Bolme, P., Fuxe, K., Agnati, L.F., Bradley, R. and Smythies, J., Cardiovascular effects of morphine and opioid peptides following intracisternal administration in chloralose-anesthetized rats, Eur. J. Pharmacol., 48 (1978) 319-324.
6. Burton, C.K., Ho, I.K. and Hoskins, B., Effect of cyclo(Leu-Gly) on cyclic GMP-phosphodiesterase activity changes associated with development of tolerance to morphine-induced antinociception, catalepsy, respiratory depression and mydriasis, J. Pharmacol. Exp. Ther., 258 (1991) 871-876.
7. Collado-Escobar, D., Rovati, L.C., Ganzetti, I., Cocchi, D., Panerai, A.E. and Li, C.H., The β-endorphin-induced secretion of growth hormone but not of prolactin is inhibited by an endogenous opioid antagonist, Eur. J. Pharmacol., 129 (1986) 385-387.
8. Deakin, J.F.W., Doströvsky, J.O. and Smyth, D.G., Influence of N-terminal acetylation and C-terminal proteolysis on the analgesic activity of β-endorphin, Biochem. J., 189 (1980) 501-506.
9. Dores, R.M., Jain, M. and Akil, H., Characterization of the forms of β-endorphin and α-MSH in the caudal medulla of the rat and guinea pig, Brain Res., 377 (1986) 251-260.
10. Hirsch, M.D. and Millington, W.R., Endoproteolytic conversion of β-endorphin-1-31 to β-endorphin-1-27 potentiates its central cardioregulatory activity, Brain Res., 550 (1991) 61-68.
11. Hirsch, M.D. and O'Donohue, T.L., Structural modifications of pro-opiomelanocortin-derived peptides alter their behavioral effects markedly, J. Pharmacol. Exp. Ther., 237 (1986) 378-385.
12. Hoffman, P.L., Walter, R. and Bulat, M., An enzymatically stable peptide with activity in the central nervous system: its penetration through the blood-CSF barrier, Brain Res., 122 (1977) 87-94.
13. Kee, A.J., Smith, R.C., Gross, A.S., Madsen, D.C. and Rowe, B., The effect of dipeptide structure on dipeptide and amino acid clearance in rats, Metabolism, 43 (1994) 1373-1378.
14. Koelle, G.B., Massoulié, J., Eugène, D. and Melone, M.A.B., Effects of glycyl-L-glutamine in vitro on the molecular forms of acetylcholinesterase in the preganglionically denervated superior cervical ganglion of the cat, Proc. Natl. Acad. Sci., 85 (1988) 1686-1690.
15. Loh, Y.P., Molecular mechanisms of β-endorphin biosynthesis, Biochem. Pharmacol. 44 (1992) 843-849.
16. 12 acetylcholinesterase but not of nicotinic acetylcholine receptors in quail embryonic myotubes by a cyclic AMP-independent mechanism, J. Neurochem., 54 (1990) 1122-1129.
17. McCain, H.W., Bilotta, J. and Lamster, I.B., Endorphinergic modulation of immune function: potent action of the dipeptide glycyl-L-glutamine, Life Sci., 41 (1987) 169-176.
18. Nicolas, P. and Li, C.H., β-Endorphin-(1-27) is a naturally occurring antagonist to etorphine-induced analgesia, Proc. Natl. Acad. Sci. USA, 82 (1985) 3178-3181.
19. Nock, B., Giordano, A.L., Cicero, T.J. and O'Connor, L.H., Affinity of drugs and peptides for U-69,593-sensitive and -insensitive kappa-opiate binding sites: the U-69-593-insensitive site appears to be the beta endorphin-specific epsilon receptor, J. Pharmacol. Exp. Ther., 254 (1990) 412-419.
20. Owen, M.D., Millington, W.R. and Zaloga, G.P., Glycyl-L-glutamine, a β-endorphin-derived peptide, restores blood pressure following acute hemorrhage in rats, Anesthesiology, 83 (1995) A541.
21. Pardridge, W.M., Receptor-mediated peptide transport through the blood-brain barrier, Endocr. Rev., 7 (1986) 314-330.
22. Parish, D.C., Smyth, D.G., Normanton, J.R. and Wolstencroft, J.H., Glycyl glutamine, an inhibitory neuropeptide derived from β-endorphin, Nature, 306 (1983) 267-270.
23. 3H]glycyl-L-glutamine [β-endorphin(30-31)] binding sites in bovine forebrain, Soc. Neurosci. Abstr., 22 (1996) 1768.
24. Petty, M.A. and De Jong, W., Cardiovascular effects of β-endorphin after microinjection into the nucleus tractus solitarii of the anaesthetized rat, Eur. J. Pharmacol., 81 (1982) 449-457.
25. Petty, M.A. and Sitsen, J.M.A., Central hypotensive influence of opioid peptides. In F.P. Nijkamp and D. de Wied (Eds.), Hypertension, Brain Catecholamines and Peptides, Elsevier, New York, 1989, pp. 59-67.
26. Prasad, C., Bioactive cyclic dipeptides, Peptides, 16 (1995) 151-164.
27. Prasad, C., Matsui, T. and Peterkofsky, A., Antagonism of ethanol narcosis by histidyl-proline diketopiperazine, Nature, 268 (1977) 142-144.
28. Rainbow, T.C., Flexner, J.B., Flexner, L.B., Distribution, survival and biological effects in mice of a behaviorally active, enzymatically stable peptide: pharmacokinetics of cyclo (Leu-Gly) and puromycin-induced amnesia, Pharmacol. Biochem. Behav., 10 (1979) 787-793.
29. Resch, G.E. and Millington, W.R., Glycyl-L-glutamine antagonizes α-MSH-elicited thermogenesis, Peptides, 14 (1993) 971-975.
30. Sakurada, S., Sakurada, T., Jin, H., Sato, T., Kisara, K., Sasaki, Y. and Suzuki, K., Antinociceptive activities of synthetic dipeptides in mice, J. Pharm. Pharmacol., 34 (1982) 750-751.
31. Schadt, J.C. and Ludbrook, J., Hemodynamic and neurohumoral responses to acute hypovolemia in conscious mammals, Am. J. Physiol., 260 (1991) H305-H318.
32. Sitsen, J.M.A., Van Ree, J.M. and De Jong, W., Cardiovascular and respiratory effects of β-endorphin in anesthetized and conscious rats, J. Cardiovasc. Pharmacol., 4 (1982) 883-888.
33. Suh, H.H., Tseng, L.-F. and Li, C.H., Beta-endorphin-(1-27) antagonizes beta-endorphin-induced hypothermia in mice, Peptides, 8 (1987) 123-126.
34. Takemori, A.E. and Portoghese, P.S., The mixed antinociceptive agonist-antagonist activity of β-endorphin(1-27) in mice, Life Sci., 53 (1993) 1049-1052.
35. Unal, C.B., Owen, M.D. and Millington, W.R., β-Endorphin-induced cardiorespiratory depression is inhibited by glycyl-L-glutamine, a dipeptide derived from β-endorphin processing, J. Pharmacol. Exp. Ther., 271 (1994) 952-958.
36. Van Giersbergen, P.L.M., De Lang, H. and De Jong, W., Effects of dynorphin A(1-13) and fragments of β-endorphin on blood pressure and heart rate of anesthetized rats, Can. J. Physiol. Pharmacol., 69 (1991) 327-333.
37. Van Giersbergen, P.L.M., Van den Berg, M.H., Eijgelshoven, M.H.J., Cox-van Put, J., Van den Berg, D.T.W.M., De Kloet, E.R. and De Jong, W., Endogenous opioid peptides, glucocorticoids, and shock: specificity, site, and mechanism of action. In G. Kunos and J. Ciriello (Eds.), Central Neural Mechanisms in Cardiovascular Regulation, Birkhäuser, Boston, 1991, pp. 137-152.
38. Vazquez, J.A., Raghunath, M. and Adibi, S.A., Uptake and hydrolysis of glycylglutamine at the blood-brain barrier, Metabolism, 41 (1992) 121-124.
39. Walter, R., Hoffman, P.L., Flexner, J.B. and Flexner, L.B., Neurohypophyseal hormones, analogs, and fragments: their effect on puromycin-induced amnesia, Proc. Natl. Acad. Sci. USA, 72 (1975) 4180-4184.
40. Walter, R., Ritzmann, R.F., Bhargava, H.N. and Flexner, L.B., Prolyl-leucyl-glycinamide, cyclo(leucylglycine), and derivatives block development of physical dependence on morphine in mice, Proc. Natl. Acad. Sci. USA, 76 (1979) 518-520.
41. Zakarian, S. and Smyth, D.G., β-Endorphin is processed differently in specific regions of rat pituitary and brain, Nature, 296 (1982) 250-252.
42. Zlokovic, B.V., Begley, D.J. and Chain, D.G., Blood-brain barrier permeability to dipeptides and their constituent amino acids, Brain Res., 271 (1983) 65-71.